Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation.
暂无分享,去创建一个
S. Duga | C. Santoro | M. Platé | F. Peyvandi | R. Asselta | M. Robusto
[1] I. Guella,et al. Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency , 2015, Thrombosis and Haemostasis.
[2] A. Lebreton,et al. Natural history of patients with congenital dysfibrinogenemia. , 2015, Blood.
[3] A. Casini,et al. Congenital Fibrinogen Disorders: An Update , 2013, Seminars in Thrombosis & Hemostasis.
[4] Rustem I. Litvinov,et al. Mechanisms of fibrin polymerization and clinical implications. , 2013, Blood.
[5] Raja Mazumder,et al. Structure-based Comparative Analysis and Prediction of N-linked Glycosylation Sites in Evolutionarily Distant Eukaryotes , 2013, Genom. Proteom. Bioinform..
[6] E. Rapp,et al. Glycoproteomic analysis of human fibrinogen reveals novel regions of O-glycosylation. , 2012, Journal of proteome research.
[7] S. Duga,et al. Congenital hypofibrinogenemia: characterization of two missense mutations affecting fibrinogen assembly and secretion. , 2008, Blood cells, molecules & diseases.
[8] S. Acharya,et al. Rare inherited disorders of fibrinogen , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.
[9] M. Neerman-Arbez,et al. Molecular mechanisms accounting for fibrinogen deficiency: from large deletions to intracellular retention of misfolded proteins , 2007, Journal of thrombosis and haemostasis : JTH.
[10] P. de Moerloose,et al. Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations , 2007, Human mutation.
[11] Guillaume Vogt,et al. Gain-of-glycosylation mutations. , 2007, Current opinion in genetics & development.
[12] S. Duga,et al. The molecular basis of quantitative fibrinogen disorders , 2006, Journal of thrombosis and haemostasis : JTH.
[13] D. Triplett,et al. Thrombophilias and recurrent pregnancy loss. , 2006, Seminars in reproductive medicine.
[14] M. Bertrand,et al. LETTERS TO THE EDITOR: Four cases of hypofibrinogenemia associated with four novel mutations , 2005, Journal of thrombosis and haemostasis : JTH.
[15] M. Mosesson. Fibrinogen and fibrin structure and functions , 2005, Journal of thrombosis and haemostasis : JTH.
[16] S. Brennan,et al. Novel γ230 Asn→Asp substitution in fibrinogen Middlemore associated hypofibrinogenaemia , 2005, Thrombosis and Haemostasis.
[17] B. Kudryk,et al. Fibrinogen Biosynthesis , 2001, Thrombosis and Haemostasis.
[18] V. V. van Hinsbergh,et al. Aberrant fibrin formation and cross-linking of fibrinogen Nieuwegein, a variant with a shortened Aalpha-chain, alters endothelial capillary tube formation. , 2001, Blood.
[19] B. Lämmle,et al. Fibrinogen Milano XIII (Aα 19 Arg→Gly) , 1999 .
[20] J. Mimuro,et al. Fibrinogen Niigata With Impaired Fibrin Assembly: An Inherited Dysfibrinogen With a Bβ Asn-160 to Ser Substitution Associated With Extra Glycosylation at Bβ Asn-158 , 1999 .
[21] S. Brennan,et al. Oligosaccharide Configuration of Fibrinogen Kaiserslautern: Electrospray Ionisation Analysis of Intact γ Chains , 1998, Thrombosis and Haemostasis.
[22] R. Doolittle,et al. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin , 1997, Nature.
[23] B. Lämmle,et al. A frameshift mutation in Exon V of the A alpha-chain gene leading to truncated A alpha-chains in the homozygous dysfibrinogen Milano III. , 1994, The Journal of biological chemistry.
[24] S. Lord,et al. Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461-610 (Lys 461 AAA-->stop TAA) , 1992 .
[25] P. Mannucci,et al. Sustained correction of the bleeding time in an afibrinogenaemic patient after infusion of fresh frozen plasma , 1992, British journal of haematology.
[26] H. Hirata,et al. Fibrinogen Lima: a homozygous dysfibrinogen with an A alpha-arginine-141 to serine substitution associated with extra N-glycosylation at A alpha-asparagine-139. Impaired fibrin gel formation but normal fibrin-facilitated plasminogen activation catalyzed by tissue-type plasminogen activator. , 1992, The Journal of clinical investigation.
[27] H. Hirata,et al. An A alpha Ser-434 to N-glycosylated Asn substitution in a dysfibrinogen, fibrinogen Caracas II, characterized by impaired fibrin gel formation. , 1991, The Journal of biological chemistry.
[28] J. Nickerson,et al. Modification of fibrinogen chains during synthesis: glycosylation of B beta and gamma chains. , 1981, Biochemistry.
[29] S. Shapiro,et al. Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism. , 1974, The Journal of clinical investigation.
[30] W. Nieuwenhuizen. Fibrinogen : XVIth International Fibrinogen Workshop , 2001 .
[31] R. Colman. Hemostasis and thrombosis: Basic principles and clinical practice , 1987 .